Aclipse Therapeutics
PrivateLast Round
Grant
Apr 20, 2022
Total Funding Raised
$4.4M
Company Overview
Aclipse Therapeutics is a biopharmaceutical company that develops novel and differentiated drugs to treat diseases with significant unmet medical needs, focusing on neuromuscular and gastrointestinal disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aclipse Therapeutics Comparables
Compare Aclipse Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CinDome Pharma | 81% | |
| Collaborative Medicinal Development | 81% | |
| Processa Pharmaceuticals | 78% |
Aclipse Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 20, 2022 | ||||
| Grant | Jan 26, 2021 | ||||
| Series A | Sep 30, 2020 | ||||
| Grant | Sep 29, 2020 |
Key People
Founding team and executive leadership
Aclipse Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FightMND | Grant |
| Congressionally Directed Medical Research Programs | Grant |
| Medical Research Council | Grant |
| Gordian Life Sciences | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 52% MoM.
- Mar 25, 2025
Monthly visitors increased 40% MoM.
Aclipse Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aclipse Therapeutics's valuation, stock price, and market status.
Is Aclipse Therapeutics a public or private company?
Aclipse Therapeutics is a private company.
What is the current stock price of Aclipse Therapeutics?
Aclipse Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Aclipse Therapeutics worth (valuation)?
Valuation information for Aclipse Therapeutics is not publicly available.
Can I buy Aclipse Therapeutics stock?
Aclipse Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aclipse Therapeutics's last funding round?
Aclipse Therapeutics's most recent funding round was Grant on April 20, 2022.
Who are the main investors in Aclipse Therapeutics?
Key investors in Aclipse Therapeutics include FightMND, Congressionally Directed Medical Research Programs, Medical Research Council, Gordian Life Sciences.
Will Aclipse Therapeutics IPO soon?
No public IPO plans have been announced for Aclipse Therapeutics.
How can I track Aclipse Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aclipse Therapeutics's secondary market activity and sign up for updates.